Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

OMI vs HSIC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OMI
Owens & Minor, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$171M
5Y Perf.-71.8%
HSIC
Henry Schein, Inc.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$8.09B
5Y Perf.+24.3%

OMI vs HSIC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OMI logoOMI
HSIC logoHSIC
IndustryMedical - DistributionMedical - Distribution
Market Cap$171M$8.09B
Revenue (TTM)$2.76B$13.18B
Net Income (TTM)$-1.10B$398M
Gross Margin29.1%
Operating Margin1.0%5.8%
Forward P/E2.3x13.3x
Total Debt$320M$3.69B
Cash & Equiv.$282M$156M

OMI vs HSICLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OMI
HSIC
StockMay 20Feb 26Return
Owens & Minor, Inc. (OMI)10028.2-71.8%
Henry Schein, Inc. (HSIC)100124.3+24.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: OMI vs HSIC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HSIC leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Owens & Minor, Inc. is the stronger pick specifically for valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
OMI
Owens & Minor, Inc.
The Value Play

OMI is the clearest fit if your priority is value.

  • Lower P/E (2.3x vs 13.3x)
Best for: value
HSIC
Henry Schein, Inc.
The Income Pick

HSIC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 0.73
  • Rev growth 4.0%, EPS growth 7.2%, 3Y rev CAGR 1.4%
  • 5.3% 10Y total return vs OMI's -86.2%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthHSIC logoHSIC4.0% revenue growth vs OMI's -74.2%
ValueOMI logoOMILower P/E (2.3x vs 13.3x)
Quality / MarginsHSIC logoHSIC3.0% margin vs OMI's -39.8%
Stability / SafetyHSIC logoHSICBeta 0.73 vs OMI's 1.44
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)HSIC logoHSIC+5.9% vs OMI's -71.1%
Efficiency (ROA)HSIC logoHSIC3.6% ROA vs OMI's -44.9%, ROIC 7.1% vs 1.8%

OMI vs HSIC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OMIOwens & Minor, Inc.
FY 2025
Diabetes Product
56.9%$783M
Product and Service, Other
20.9%$288M
Wound Care
13.7%$189M
Urology
8.4%$116M
HSICHenry Schein, Inc.
FY 2018
Healthcare Distribution
96.1%$12.7B
Technology
3.9%$509M

OMI vs HSIC — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHSICLAGGINGOMI

Income & Cash Flow (Last 12 Months)

HSIC leads this category, winning 4 of 5 comparable metrics.

HSIC is the larger business by revenue, generating $13.2B annually — 4.8x OMI's $2.8B. HSIC is the more profitable business, keeping 3.0% of every revenue dollar as net income compared to OMI's -39.8%. On growth, HSIC holds the edge at +7.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricOMI logoOMIOwens & Minor, In…HSIC logoHSICHenry Schein, Inc.
RevenueTrailing 12 months$2.8B$13.2B
EBITDAEarnings before interest/tax$277M$1.1B
Net IncomeAfter-tax profit-$1.1B$398M
Free Cash FlowCash after capex-$353M$561M
Gross MarginGross profit ÷ Revenue+29.1%
Operating MarginEBIT ÷ Revenue+1.0%+5.8%
Net MarginNet income ÷ Revenue-39.8%+3.0%
FCF MarginFCF ÷ Revenue-12.8%+4.3%
Rev. Growth (YoY)Latest quarter vs prior year-146.3%+7.7%
EPS Growth (YoY)Latest quarter vs prior year+4.5%+14.9%
HSIC leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

OMI leads this category, winning 4 of 4 comparable metrics.

On an enterprise value basis, OMI's 1.7x EV/EBITDA is more attractive than HSIC's 10.9x.

MetricOMI logoOMIOwens & Minor, In…HSIC logoHSICHenry Schein, Inc.
Market CapShares × price$171M$8.1B
Enterprise ValueMkt cap + debt − cash$209M$11.6B
Trailing P/EPrice ÷ TTM EPS-0.16x21.56x
Forward P/EPrice ÷ next-FY EPS est.2.31x13.26x
PEG RatioP/E ÷ EPS growth rate6.84x
EV / EBITDAEnterprise value multiple1.70x10.87x
Price / SalesMarket cap ÷ Revenue0.06x0.61x
Price / BookPrice ÷ Book value/share1.79x
Price / FCFMarket cap ÷ FCF14.12x
OMI leads this category, winning 4 of 4 comparable metrics.

Profitability & Efficiency

HSIC leads this category, winning 6 of 8 comparable metrics.

HSIC delivers a 8.2% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-21 for OMI. On the Piotroski fundamental quality scale (0–9), HSIC scores 4/9 vs OMI's 2/9, reflecting mixed financial health.

MetricOMI logoOMIOwens & Minor, In…HSIC logoHSICHenry Schein, Inc.
ROE (TTM)Return on equity-21.1%+8.2%
ROA (TTM)Return on assets-44.9%+3.6%
ROICReturn on invested capital+1.8%+7.1%
ROCEReturn on capital employed+1.3%+9.8%
Piotroski ScoreFundamental quality 0–924
Debt / EquityFinancial leverage0.77x
Net DebtTotal debt minus cash$38M$3.5B
Cash & Equiv.Liquid assets$282M$156M
Total DebtShort + long-term debt$320M$3.7B
Interest CoverageEBIT ÷ Interest expense-0.12x4.59x
HSIC leads this category, winning 6 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

HSIC leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in HSIC five years ago would be worth $8,746 today (with dividends reinvested), compared to $655 for OMI. Over the past 12 months, HSIC leads with a +5.9% total return vs OMI's -71.1%. The 3-year compound annual growth rate (CAGR) favors HSIC at -4.0% vs OMI's -49.9% — a key indicator of consistent wealth creation.

MetricOMI logoOMIOwens & Minor, In…HSIC logoHSICHenry Schein, Inc.
YTD ReturnYear-to-date-3.4%-8.2%
1-Year ReturnPast 12 months-71.1%+5.9%
3-Year ReturnCumulative with dividends-87.4%-11.7%
5-Year ReturnCumulative with dividends-93.5%-12.5%
10-Year ReturnCumulative with dividends-86.2%+5.3%
CAGR (3Y)Annualised 3-year return-49.9%-4.0%
HSIC leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

HSIC leads this category, winning 2 of 2 comparable metrics.

HSIC is the less volatile stock with a 0.73 beta — it tends to amplify market swings less than OMI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HSIC currently trades 79.0% from its 52-week high vs OMI's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOMI logoOMIOwens & Minor, In…HSIC logoHSICHenry Schein, Inc.
Beta (5Y)Sensitivity to S&P 5001.44x0.73x
52-Week HighHighest price in past year$9.55$89.29
52-Week LowLowest price in past year$1.84$61.95
% of 52W HighCurrent price vs 52-week peak+23.5%+79.0%
RSI (14)Momentum oscillator 0–10046.539.1
Avg Volume (50D)Average daily shares traded690K1.2M
HSIC leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

HSIC leads this category, winning 1 of 1 comparable metric.

Wall Street rates OMI as "Hold" and HSIC as "Hold". Consensus price targets imply 78.6% upside for OMI (target: $4) vs 22.6% for HSIC (target: $86).

MetricOMI logoOMIOwens & Minor, In…HSIC logoHSICHenry Schein, Inc.
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$4.00$86.43
# AnalystsCovering analysts1032
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises01
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+10.5%
HSIC leads this category, winning 1 of 1 comparable metric.
Key Takeaway

HSIC leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). OMI leads in 1 (Valuation Metrics).

Best OverallHenry Schein, Inc. (HSIC)Leads 5 of 6 categories
Loading custom metrics...

OMI vs HSIC: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is OMI or HSIC a better buy right now?

For growth investors, Henry Schein, Inc.

(HSIC) is the stronger pick with 4. 0% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 6x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate Owens & Minor, Inc. (OMI) a "Hold" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — OMI or HSIC?

On forward P/E, Owens & Minor, Inc.

is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — OMI or HSIC?

Over the past 5 years, Henry Schein, Inc.

(HSIC) delivered a total return of -12. 5%, compared to -93. 5% for Owens & Minor, Inc. (OMI). Over 10 years, the gap is even starker: HSIC returned +5. 3% versus OMI's -86. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — OMI or HSIC?

By beta (market sensitivity over 5 years), Henry Schein, Inc.

(HSIC) is the lower-risk stock at 0. 73β versus Owens & Minor, Inc. 's 1. 44β — meaning OMI is approximately 97% more volatile than HSIC relative to the S&P 500.

05

Which is growing faster — OMI or HSIC?

By revenue growth (latest reported year), Henry Schein, Inc.

(HSIC) is pulling ahead at 4. 0% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: Henry Schein, Inc. grew EPS 7. 2% year-over-year, compared to -201. 1% for Owens & Minor, Inc.. Over a 3-year CAGR, HSIC leads at 1. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — OMI or HSIC?

Henry Schein, Inc.

(HSIC) is the more profitable company, earning 3. 0% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 3. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HSIC leads at 5. 7% versus 1. 0% for OMI. At the gross margin level — before operating expenses — HSIC leads at 29. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is OMI or HSIC more undervalued right now?

On forward earnings alone, Owens & Minor, Inc.

(OMI) trades at 2. 3x forward P/E versus 13. 3x for Henry Schein, Inc. — 11. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 78. 6% to $4. 00.

08

Which pays a better dividend — OMI or HSIC?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is OMI or HSIC better for a retirement portfolio?

For long-horizon retirement investors, Henry Schein, Inc.

(HSIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73)). Both have compounded well over 10 years (HSIC: +5. 3%, OMI: -86. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between OMI and HSIC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

OMI

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

HSIC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 17%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform OMI and HSIC on the metrics below

Revenue Growth>
%
(OMI: -146.3% · HSIC: 7.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.